Cargando…

Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process

OBJECTIVE: To develop an evidence-based guideline for the diagnosis and treatment of antipsychotic-induced hyperprolactinemia by adapting existing high-quality clinical guidelines with a view to improve the clinical symptoms and long-term quality of life of patients by providing appropriate manageme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hye Ri, Kim, Sun Mi, Kang, Won Sub, Jeon, Hong Jun, Jang, Seung-Ho, Jon, Duk-In, Hong, Jeongwan, Jeong, Jong-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335910/ https://www.ncbi.nlm.nih.gov/pubmed/37424413 http://dx.doi.org/10.9758/cpn.22.979

Ejemplares similares

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
por: Rosenbloom, Arlan L.
Publicado: (2010)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Correction: Hyperprolactinemia with antipsychotic drugs in children and adolescents
por: Rosenbloom, Arlan L
Publicado: (2013)

Hyperprolactinemia with antipsychotics and the need for magnetic resonance imaging
por: Molina Liétor, M.D.C., et al.
Publicado: (2022)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
por: Montejo, A.L., et al.
Publicado: (2022)

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

The Development of Evidence-Based Guideline for Diagnosis and Management of Headache in Korea
por: Kim, Sun Mi, et al.
Publicado: (2019)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Hyperprolactinemia in patients taking antipsychotics: the importance of a shared approach between psychiatry and endocrinology
por: Mousinho, M., et al.
Publicado: (2023)

Corrigendum: Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis
por: Lu, Zhe, et al.
Publicado: (2022)

Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
por: Wang, Zhongbao, et al.
Publicado: (2023)

Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)

Prescription Patterns for Patients with Schizophrenia in Korea: A Focus on Antipsychotic Polypharmacy
por: Kim, Hee-Yun, et al.
Publicado: (2014)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions
por: Johnston, A. N., et al.
Publicado: (2018)

2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
por: Ko, Seung-Hyun, et al.
Publicado: (2011)

Pharmacological causes of hyperprolactinemia
por: Torre, Daria La, et al.
Publicado: (2007)

Drug Induced Hyperprolactinemia
por: Venkatanarasu, Ashok, et al.
Publicado: (2021)

Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia
por: Almazrouei, Raya, et al.
Publicado: (2021)

2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea
por: Kim, Bo-Yeon, et al.
Publicado: (2021)

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
por: Ivanova, Svetlana, et al.
Publicado: (2016)

Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
por: Suh, Dong Hoon, et al.
Publicado: (2018)

Complete mitochondrial genome of the roe deer Capreolus pygargus tianschanicus (Cervidae) from Korea
por: Kim, Hye Ri, et al.
Publicado: (2017)

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia
por: Osmanova, Diana Z., et al.
Publicado: (2019)

An Audit on the Monitoring and Management of Hyperprolactinemia in Inpatient Adults on Regular Antipsychotics in 8 Acute Wards in an NHS Mental Health Trust
por: Zhang, Peter, et al.
Publicado: (2022)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

2018 Guidelines for the Management of Dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2018 Guidelines for the management of dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

Hair loss and hyperprolactinemia in women
por: Lutz, Gerhard
Publicado: (2012)

Macroprolactinemia: new insights in hyperprolactinemia
por: Kasum, Miro, et al.
Publicado: (2012)

Hyperprolactinemia in Children with Subclinical Hypothyroidism
por: Sharma, Neera, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8aq0p8enbai8v3cf5gqk2vpfjl